Tirzepatide
GLP-1 Injection
Tirzepatide is a cutting-edge medication that allows patients to address weight management in a way that was previously thought to be unattainable. While Tirzepatide initially garnered attention for its effectiveness in managing blood sugar levels, it soon revealed its potential in another crucial aspect of health - weight management.
Tirzepatide is a dual function GLP1/GIP receptor agonist, that is taken in the form of once-weekly subcutaneous injection. Together, these functions can help reduce hunger, slow gastric emptying and treat insulin resistance allowing you to lose weight.
Key Benefits
-
Weight Loss
-
Reduced inflammatory biomarkers
-
Enhanced insulin synthesis
-
Blood sugar regulation
-
Controlled food cravings
-
Slow digestion to maintain satiety
-
Significant improvement in cardiovascular risk factors associated with obesity
Concerns treated
-
Weight
-
Insulin Resistance
-
Appetite
-
Blood Sugar
-
Cardiovascular Health
-
High Cholesterol
What to Expect
-
Always free consultations
-
InBody Analysis Throughout
-
Continuous support
-
Weekly, bi-weekly, or monthly follow ups
-
Education
-
Diet and lifestyle coaching
-
Symptom management
-
Monthly Lipotropic Injections
How Does Tirzepatide Work?
Tirzepatide works by targeting the dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide 1 (GLP-1) receptor agonist, making it the first weight loss and diabetes care medication that targets 2 receptor agonists. These processes slow down digestion, improve glycemic control and help people feel more full for longer after eating meals. All of this can lead to body weight reduction and weight control.
GIP is a hormone that stimulates the release of insulin, which not only helps control blood sugar levels, but also promotes muscle growth by encouraging protein build-up and discouraging protein breakdown in muscle tissue.
Tirzepatide works by allowing GIP and GLP-1 to stimulate the pancreas to increase the amount of insulin released in response to meals, encouraging healthy blood glucose regulation.
How Does semaglutide Work?
Semaglutide mimics a hormone called glucagon-like peptide-1 (or GLP-1) that targets areas in the brain that regulate appetite and food intake. Your digestive tract releases this incretin hormone after you’ve eaten a meal, lowering your blood sugar by triggering insulin release to more efficiently manage blood sugar levels. Doing so helps control appetite, and patients taking Semaglutide for weight loss can lose up to one to two pounds per week. Diet and exercise is key to results, as maintaining healthy eating habits is necessary.
Medical Provider
Kelly Siegel, Certified Nurse Practitioner
Kelly Siegel, CNP is the medical provider for the Pura Vida Wellness Medical Weight loss program. She has almost 40 years of experience as a registered nurse in the State of Ohio. She has been a Certified Nurse Practitioner for more than 26 years. Throughout her career, she has practiced locally working at Cleveland Clinic, Lake Hospitals and UH in Cleveland. She has held appointments to the faculty of Case Western Reserve School of Medicine and Frances Payne Bolton School of Nursing. In addition, she was appointed clinical faculty with the Ohio University’s Heritage College of Osteopathic Medicine. She has been an invited lecturer at many medical conferences as well.
Kelly comes with a wealth of experience managing complex and chronic health conditions. She feels that obesity is a significant chronic illness that is an epidemic in the United States. She believes that a medical weight loss program that includes prescription and non-prescription weight loss medications and supplements, combined with coaching for behavioral and lifestyle changes offers a realistic & holistic approach that promotes overall health, wellness and sustained long-term weight loss.
Safety and Transparency First:
Important Information for Your Care
At Pura Vida Wellness, we are committed to providing safe and effective treatments. We work with an FDA-registered 503B outsourcing facility that follows stringent quality control measures and complies with Current Good Manufacturing Practices (cGMP). This ensures the highest standards of sterility, safety, and consistency in the production of our compounded medications.
Please note that while the facility we partner with is FDA-registered, the compounded medications themselves are not FDA-approved. Compounded products may still be legally prescribed, and your healthcare provider may issue you a prescription for compounded medications based on your medical consultation. These compounded medications are custom-made formulations designed to meet individual patient needs and are not subject to the same premarket approval process as commercially manufactured drugs.
As always, we recommend discussing any questions about your treatment with our medical team to ensure you fully understand the potential risks and benefits.
Semaglutide FAQ
The most common side effects include abdominal pain, nausea, vomiting, constipation, diarrhea, indigestion, and headache. Nausea, vomiting, and diarrhea are particularly common when starting treatment or during dose increases, but these symptoms typically improve over time for most patients. We’re here to help manage any symptoms you may experience. Many side effects can be alleviated with medication or simple lifestyle adjustments, such as staying hydrated, replenishing electrolytes, and making dietary changes. Our team is committed to supporting you every step of the way to ensure your treatment is as comfortable and effective as possible.
Your health and safety are our top priorities. As part of our program, we require blood work after your first 4 months and every 6 months thereafter.
This routine blood work allows our medical team to:
-
Monitor your overall health and ensure your body is responding well to the program.
-
Identify any potential deficiencies or changes that may arise.
-
Adjust your treatment plan as needed for optimal, long-term results.
-
Extensive studies on Semaglutide for weight loss show that most patients can expect to lose approximately 10-15% of their body weight, with some achieving even greater results. While individual outcomes may vary, the majority of patients begin to notice significant progress within 3 to 6 months.
Semaglutide will be prescribed as a weekly injection. Injections should be administered every 7 days. One injection should be administered on the same day each week. Semaglutide is started at a low dose that is gradually increased so it is important you use the medication exactly as directed. Do not increase any dose prior to 4 weeks.
No. Semaglutide is not covered by insurance for people who are not diabetic type 2. Fortunately, we are able to offer our compounded medication at a very competitive, low price.